Grail (GRAL) EBT Margin (2023 - 2026)
Grail's (GRAL) quarterly EBT Margin came in at 373.06% in Q2 2026, up 5699.0% on a YoY basis from 6.43% in Q2 2025, and down 19.31% quarter-over-quarter from 312.67% in Q1 2026.
Powered by 
Analysis
Grail (GRAL) EBT Margin (2023 - 2026) Analysis & Trends
Grail (GRAL) has reported EBT Margin for 4 consecutive years, with 373.06% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT Margin rose 5699.0% year-over-year to 373.06%; the trailing twelve-month figure through Jun 2026 stood at 336.79% (up 10903.0% YoY), and the FY2025 full-year result was 363.18%, up 135851.0% from the prior year.
- EBT Margin eased to 373.06% in Q2 2026 per GRAL's latest filing, from 312.67% in the prior quarter.
- Across five years, EBT Margin topped out at 208.51% in Q4 2023 and bottomed at 5125.06% in Q2 2024.
- Historically, EBT Margin has averaged 1192.31% across 4 years, with a median of 444.96% in 2025.
- The sharpest annual moves came in 2024 and 2025: EBT Margin sank 422009 bps in 2024, then surged 469501 bps in 2025.
- Over 4 years, EBT Margin stood at 208.51% in 2023, then sank by 59 bps to 331.99% in 2024, then advanced by 1 bps to 328.0% in 2025, then slipped by 14 bps to 373.06% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 373.06%, 312.67%, and 328.0% for Q2 2026, Q1 2026, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | -8.93% |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 13.54% |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 10.36% |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | -35.81% |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 2.30% |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | -0.23% |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 24.29% |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 6.87% |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | -22.65% |
| 10 | Grail | 3.61 Bn | 2.75 Bn | 21.34 Mn | -373.06% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -373.06% |
| Mar 31, 2026 | -312.67% |
| Sep 30, 2025 | -328.00% |
| Jun 30, 2025 | -430.05% |
| Mar 31, 2025 | -459.88% |
| Dec 31, 2024 | -331.99% |
| Sep 30, 2024 | -601.73% |
| Jun 30, 2024 | -5,125.06% |
| Mar 31, 2024 | -840.08% |
| Dec 31, 2023 | -208.51% |
| Oct 1, 2023 | -4,391.75% |
| Jun 30, 2023 | -904.97% |